InvestorsHub Logo
Followers 19
Posts 459
Boards Moderated 0
Alias Born 07/13/2022

Re: None

Thursday, 12/01/2022 12:22:25 PM

Thursday, December 01, 2022 12:22:25 PM

Post# of 8607
This is huge.

Roche has submitted data from the IMscin001 study to health authorities, seeking approval for the subcutaneous option across all approved indications of IV Tecentriq

Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News